D
Daniel Serón
Researcher at University of Barcelona
Publications - 164
Citations - 10086
Daniel Serón is an academic researcher from University of Barcelona. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 45, co-authored 163 publications receiving 9378 citations. Previous affiliations of Daniel Serón include École Normale Supérieure & Autonomous University of Barcelona.
Papers
More filters
Journal ArticleDOI
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Kim Solez,Robert B. Colvin,Lorraine C. Racusen,Mark Haas,Banu Sis,Michael Mengel,Philip F. Halloran,William M. Baldwin,G. Banfi,A. B. Collins,Fernando G. Cosio,D. S. R. David,Cinthia B. Drachenberg,Gunilla Einecke,Agnes B. Fogo,Ian W. Gibson,Denis Glotz,Samy S. Iskandar,Edward S. Kraus,Evelyne Lerut,Roslyn B. Mannon,Michael J. Mihatsch,Brian J. Nankivell,Volker Nickeleit,John C. Papadimitriou,Parmjeet Randhawa,Heinz Regele,Karine Renaudin,Ian S.D. Roberts,Daniel Serón,Rex Neal Smith,Marialuisa Valente +31 more
TL;DR: Emerging research data led to the establishment of collaborative working groups addressing issues like isolated ‘v’ lesion and incorporation of omics‐technologies, paving the way for future combination of graft biopsy and molecular parameters within the Banff process.
Journal ArticleDOI
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').
Kim Solez,Robert B. Colvin,Lorraine C. Racusen,Banu Sis,Philip F. Halloran,Patricia E. Birk,Patricia Campbell,Marilia Cascalho,A. B. Collins,Anthony J. Demetris,Cinthia B. Drachenberg,Ian W. Gibson,Paul C. Grimm,Mark Haas,Evelyne Lerut,Helen Liapis,Roslyn B. Mannon,P. B. Marcus,Michael Mengel,Michael J. Mihatsch,Brian J. Nankivell,Volker Nickeleit,John C. Papadimitriou,Jeffrey L. Platt,Parmjeet Randhawa,Ian Roberts,L. Salinas-Madriga,Daniel R. Salomon,Daniel Serón,M. Sheaff,Jan J. Weening +30 more
TL;DR: The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15–21 July 2005, and major outcomes included the elimination of the non‐specific term ‘chronic allograft nephropathy’ (CAN) and the recognition of the entity of chronic antibody‐mediated rejection.
Journal ArticleDOI
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.
Lorraine C. Racusen,Robert B. Colvin,Kim Solez,Michael J. Mihatsch,Philip F. Halloran,Patricia Campbell,Michael Cecka,Jean Pierre Cosyns,Anthony J. Demetris,Michael C. Fishbein,Agnes B. Fogo,Peter N. Furness,Ian W. Gibson,Denis Glotz,Pekka Häyry,Lawrence Hunsickern,Michael Kashgarian,Ronald H. Kerman,Alex J. Magil,Robert A. Montgomery,Kunio Morozumi,Volker Nickeleit,Parmjeet Randhawa,Heinz Regele,Daniel Serón,Surya V. Seshan,Stale Sund,Kiril Trpkov +27 more
TL;DR: This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001, to be revisited as additional data accumulate in this important area of renal transplantation.
Journal ArticleDOI
Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss
Francesc Moreso,Meritxell Ibernon,M. Gomà,Marta Carrera,Xavier Fulladosa,Miguel Hueso,Salvador Gil-Vernet,Josep M. Cruzado,Joan Torras,Josep M. Grinyó,Daniel Serón +10 more
TL;DR: In protocol biopsies, the detrimental effect of interstitial fibrosis/tubular atrophy on long‐term graft survival is modulated by SCR, and Cox regression analysis showed that SCR with CAN and hepatitis C virus were independent predictors of graft survival.
Journal ArticleDOI
Early protocol renal allograft biopsies and graft outcome
Daniel Serón,Francesc Moreso,Jordi Bover,Enric Condom,Salvador Gil-Vernet,Conxa Cañas,Xavier Fulladosa,Joan Torras,Marta Carrera,Josep M. Grinyó,Jeroni Alsina +10 more
TL;DR: It is concluded that early protocol biopsies performed early after transplantation in stable grafts can predict graft failure due to chronic transplant nephropathy and are useful to detect patients at risk of losing their graft.